Cisco
CSCO
Apple
AAPL
Disney
DIS
4
Qualcomm
QCOM
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.6103
- +0.0003+0.05%
Trading Mar 26 10:09 ET
3.55MMarket Cap-0.01P/E (TTM)
0.6238High0.6103Low1.74KVolume0.6238Open0.6100Pre Close1.08KTurnover0.03%Turnover Ratio0.00P/E (Static)5.82MShares9.079052wk High3.33P/B3.17MFloat Cap0.361152wk Low--Dividend TTM5.20MShs Float130156.1979Historical High--Div YieldTTM2.21%Amplitude0.3610Historical Low0.6170Avg Price1Lot Size
NovaBay Pharmaceuticals Key Stats
EPS
According to the latest financial report of NovaBay Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about NovaBay Pharmaceuticals's free cash flow? The latest report shows it as -2.06M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of NovaBay Pharmaceuticals shows that the company's current ratio is 1.15, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of NovaBay Pharmaceuticals, the quick ratio is 0.75, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of NovaBay Pharmaceuticals? The latest ROE figure is -1.00K%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of NovaBay Pharmaceuticals, the total asset return on investment (ROA) is -56.83%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check NovaBay Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 65.26%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of NovaBay Pharmaceuticals, the net profit margin is -49.65%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings